+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Bladder Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bladder Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 192 Pages
  • Global
From
Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • November 2023
  • 147 Pages
  • Global
From
Diabetic Neuropathy Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Diabetic Neuropathy Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets - Product Thumbnail Image

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

  • Report
  • October 2024
  • 157 Pages
  • Global
From
Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1036 Pages
  • Global
From
Vasomotor Symptoms Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Vasomotor Symptoms Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Bladder Cancer Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bladder Cancer Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
Cough Remedy - Global Strategic Business Report - Product Thumbnail Image

Cough Remedy - Global Strategic Business Report

  • Report
  • November 2026
  • 383 Pages
  • Global
From
Ophthalmic Drugs Market Report 2026-2036 - Product Thumbnail Image

Ophthalmic Drugs Market Report 2026-2036

  • Report
  • February 2026
  • 393 Pages
  • Global
From
Breast Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Breast Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • July 2024
  • 100 Pages
  • Global
From
Acute Myeloid Leukemia (AML) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Acute Myeloid Leukemia (AML) Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 356 Pages
  • Global
From
Genito Urinary Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Genito Urinary Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2022
  • 83 Pages
  • Global
From
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 2271 Pages
  • Global
From
Overactive Bladder - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Overactive Bladder - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 130 Pages
  • Global
From
LAMEA Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

LAMEA Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 77 Pages
  • Middle East, Africa
From
Asia Pacific Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Asia Pacific Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 77 Pages
  • Asia Pacific
From
North America Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

North America Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 69 Pages
  • North America
From
Antibody Discovery Market Industry Trends and Global Forecasts to 2035: Distribution by Antibody Discovery Step, Antibody Discovery Method, Nature of, Type of Antibody, Therapeutic Area, End-user and Geographical Regions - Product Thumbnail Image

Antibody Discovery Market Industry Trends and Global Forecasts to 2035: Distribution by Antibody Discovery Step, Antibody Discovery Method, Nature of, Type of Antibody, Therapeutic Area, End-user and Geographical Regions

  • Report
  • June 2025
  • 607 Pages
  • Global
From
Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 574 Pages
  • Global
From
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1814 Pages
  • Global
From
Loading Indicator